Skip to main content

Table 3 Analyzing the underlying diseases and medications of the patients for delirium

From: Delirium risk factors in hospitalized patient: a comprehensive evaluation of underlying diseases and medications in different wards of a large Urban Hospital Center in Iran

Underlying disease

adjusted

Drug group

adjusted

OR (CI)

P-value

OR (CI)

P-value

Dementia

10.6(1.2-93.9)

0.034

Anti-diabetics

0.5(0.1-2.3)

0.152

Diabetes

2.6(6.9-7.0)

0.072

Anti-hypertensive

0.7(0.1-3.7)

0.432

Hypertension

1.1(3.0-5.3)

0.843

Diuretics

0.4(0.1-1.3)

0.124

Hyperlipidemia

–

–

Antibiotics

2.3(0.5-9.8)

0.086

Cardiovascular disease

0.9(1.2-3.0)

0.874

Anti-hyperlipidemics

0.6(0.1-2.8)

0.361

Kidney disease

1.1(2.2-6.0)

0.951

Analgesics

1.4(0.3-5.6)

0.463

Liver disease

–

–

Anti-coagulants

0.3(0.0-1.9)

0.029

Neurologic disease

8.1(6.1-31.2)

0.002

Chemotherapy

0.2(0.1-3.2)

0.078

Malignancies

3.3(8.0-10.1)

0.048

Anti-convulsant

0.2(0.1-3.2)

0.078

Lung disease

1.4(7.2-12.0)

0.737

Sedatives

2.1(0.16-3.5)

0.481

Infectious disease

1.2(5.9-15.0)

0.899

Opioids

0.9

0.861